相似文献
1
Control of melanocyte differentiation by a MITF-PDE4D3 homeostatic circuit.
Genes Dev. 2010 Oct 15;24(20):2276-81. doi: 10.1101/gad.1937710.
2
NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
Pigment Cell Melanoma Res. 2008 Dec;21(6):653-64. doi: 10.1111/j.1755-148X.2008.00503.x.
3
Hypoxia-inducible factor 1{alpha} is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells.
J Cell Biol. 2005 Jul 4;170(1):49-59. doi: 10.1083/jcb.200501067. Epub 2005 Jun 27.
4
Fitting MITF regulation of PDE4D3 into the skin pigmentation puzzle.
Pigment Cell Melanoma Res. 2011 Feb;24(1):4-6. doi: 10.1111/j.1755-148X.2010.00795.x.
5
A tissue-restricted cAMP transcriptional response: SOX10 modulates alpha-melanocyte-stimulating hormone-triggered expression of microphthalmia-associated transcription factor in melanocytes.
J Biol Chem. 2003 Nov 14;278(46):45224-30. doi: 10.1074/jbc.M309036200. Epub 2003 Aug 27.
6
Wnt/β-catenin signaling is stimulated by α-melanocyte-stimulating hormone in melanoma and melanocyte cells: implication in cell differentiation.
Pigment Cell Melanoma Res. 2011 Apr;24(2):309-25. doi: 10.1111/j.1755-148X.2010.00800.x. Epub 2011 Jan 11.
7
cAMP-binding site of PKA as a molecular target of bisabolangelone against melanocyte-specific hyperpigmented disorder.
J Invest Dermatol. 2013 Apr;133(4):1072-9. doi: 10.1038/jid.2012.425. Epub 2012 Dec 20.
8
p21-activated kinase 4 critically regulates melanogenesis via activation of the CREB/MITF and β-catenin/MITF pathways.
J Invest Dermatol. 2015 May;135(5):1385-1394. doi: 10.1038/jid.2014.548. Epub 2015 Jan 5.
9
α-Viniferin Improves Facial Hyperpigmentation via Accelerating Feedback Termination of cAMP/PKA-Signaled Phosphorylation Circuit in Facultative Melanogenesis.
Theranostics. 2018 Feb 16;8(7):2031-2043. doi: 10.7150/thno.24385. eCollection 2018.
10
CtBP2 downregulation during neural crest specification induces expression of Mitf and REST, resulting in melanocyte differentiation and sympathoadrenal lineage suppression.
Mol Cell Biol. 2011 Mar;31(5):955-70. doi: 10.1128/MCB.01062-10. Epub 2011 Jan 3.
引用本文的文献
1
Inhibition of the upregulated phosphodiesterase 4D isoforms improves SERCA2a function in diabetic cardiomyopathy.
Br J Pharmacol. 2025 Apr;182(7):1487-1507. doi: 10.1111/bph.17411. Epub 2024 Dec 11.
2
PDE4D drives rewiring of the MAPK pathway in BRAF-mutated melanoma resistant to MAPK inhibitors.
Cell Commun Signal. 2024 Nov 21;22(1):559. doi: 10.1186/s12964-024-01941-y.
3
Journey through the spectacular landscape of melanocortin 1 receptor.
Pigment Cell Melanoma Res. 2024 Sep;37(5):667-680. doi: 10.1111/pcmr.13180. Epub 2024 Jun 10.
4
Integrative QTL mapping and selection signatures in Groningen White Headed cattle inferred from whole-genome sequences.
PLoS One. 2022 Oct 26;17(10):e0276309. doi: 10.1371/journal.pone.0276309. eCollection 2022.
5
Genome-Wide Association Study for Screening and Identifying Potential Shin Color Loci in Ducks.
Genes (Basel). 2022 Aug 4;13(8):1391. doi: 10.3390/genes13081391.
6
Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
Arch Dermatol Res. 2023 Mar;315(2):215-221. doi: 10.1007/s00403-022-02343-1. Epub 2022 Mar 13.
7
Targeting GPCRs and Their Signaling as a Therapeutic Option in Melanoma.
Cancers (Basel). 2022 Jan 29;14(3):706. doi: 10.3390/cancers14030706.
8
CRTC3, a sensor and key regulator for melanogenesis, as a tunable therapeutic target for pigmentary disorders.
Theranostics. 2021 Oct 17;11(20):9918-9936. doi: 10.7150/thno.66378. eCollection 2021.
9
Behind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention.
Genes (Basel). 2021 Jul 19;12(7):1093. doi: 10.3390/genes12071093.
10
CDK7 and MITF repress a transcription program involved in survival and drug tolerance in melanoma.
EMBO Rep. 2021 Sep 6;22(9):e51683. doi: 10.15252/embr.202051683. Epub 2021 Jul 23.
本文引用的文献
1
Novel MITF targets identified using a two-step DNA microarray strategy.
Pigment Cell Melanoma Res. 2008 Dec;21(6):665-76. doi: 10.1111/j.1755-148X.2008.00505.x.
2
Regulation of eumelanin/pheomelanin synthesis and visible pigmentation in melanocytes by ligands of the melanocortin 1 receptor.
Pigment Cell Melanoma Res. 2008 Aug;21(4):477-86. doi: 10.1111/j.1755-148X.2008.00479.x. Epub 2008 Jun 27.
3
cAMP-Specific phosphodiesterase-4 enzymes in the cardiovascular system: a molecular toolbox for generating compartmentalized cAMP signaling.
Circ Res. 2007 Apr 13;100(7):950-66. doi: 10.1161/01.RES.0000261934.56938.38.
4
Biochemistry and physiology of cyclic nucleotide phosphodiesterases: essential components in cyclic nucleotide signaling.
Annu Rev Biochem. 2007;76:481-511. doi: 10.1146/annurev.biochem.76.060305.150444.
5
Melanocyte biology and skin pigmentation.
Nature. 2007 Feb 22;445(7130):843-50. doi: 10.1038/nature05660.
6
Overview of PDEs and their regulation.
Circ Res. 2007 Feb 16;100(3):309-27. doi: 10.1161/01.RES.0000256354.95791.f1.
7
Topical drug rescue strategy and skin protection based on the role of Mc1r in UV-induced tanning.
Nature. 2006 Sep 21;443(7109):340-4. doi: 10.1038/nature05098.
8
MITF: master regulator of melanocyte development and melanoma oncogene.
Trends Mol Med. 2006 Sep;12(9):406-14. doi: 10.1016/j.molmed.2006.07.008. Epub 2006 Aug 8.
9
RNA silencing identifies PDE4D5 as the functionally relevant cAMP phosphodiesterase interacting with beta arrestin to control the protein kinase A/AKAP79-mediated switching of the beta2-adrenergic receptor to activation of ERK in HEK293B2 cells.
J Biol Chem. 2005 Sep 30;280(39):33178-89. doi: 10.1074/jbc.M414316200. Epub 2005 Jul 19.
10
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.
Nature. 2005 Jul 7;436(7047):117-22. doi: 10.1038/nature03664.
Zotero 插件